Dengue, Zika and chikungunya prevention with Wolbachia-infected Aedes aegypti (population replacement) and incompatible insect technique — instead of repeated insecticide fogging

Replaces: routine fogging of cities against Aedes · Scope: urban public health · Evidence: high

The chemical problem#

Cities fight dengue mainly with insecticide fogging and temephos. Aedes aegypti is highly resistant to pyrethroids in most endemic regions, and fogging reaches few mosquitoes, which rest indoors. It exposes residents and kills pollinators. Dengue incidence has grown about 10-fold in 20 years, and invasive Aedes albopictus is spreading into southern Europe and the Russian Black Sea coast (Sochi region).

Product overview#

Wolbachia is a bacterium naturally present in about 40–60 % of insect species. When the wMel strain is introduced into Aedes aegypti, it blocks the replication of dengue, Zika and chikungunya viruses in the mosquito. Through cytoplasmic incompatibility it spreads by itself through the wild mosquito population after short releases.

• World Mosquito Program (WMP): releases in Australia, Indonesia, Brazil, Colombia, Vietnam and elsewhere.
• Yogyakarta, Indonesia (AWED cluster-randomized trial, NEJM 2021): 77 % reduction in symptomatic dengue and 86 % reduction in dengue hospitalizations in the Wolbachia areas.
• Incompatible Insect Technique (IIT): releasing Wolbachia-infected males only (which do not bite) causes sterile matings and suppresses the population. Used in Singapore, the USA (Wolbachia males from MosquitoMate) and China (combined with irradiation; near-elimination of Ae. albopictus on two islands in Guangzhou, Nature 2019).

Active ingredient / Composition#

Aedes mosquitoes carrying the wMel (replacement) or wAlbB/other strains (IIT male releases), mass-reared in local facilities.

Key facts#

Advantages#

• Self-sustaining (replacement strategy): a one-time investment per city.
• Works regardless of insecticide resistance.
• No chemical exposure for residents; protects pollinators.
• Covers several viruses at once (dengue, Zika, chikungunya).

Mode of action#

• Virus blocking: Wolbachia competes for cellular resources (lipids), primes the mosquito’s immune system and changes its cell biology, so viruses cannot replicate well and are not transmitted.
• Cytoplasmic incompatibility: uninfected females mated with infected males produce no viable eggs, so Wolbachia-infected females have a reproductive advantage and the trait spreads.

Application#

Limitations#

• Needs mass-rearing facilities, a regulatory pathway and public acceptance.
• IIT needs continuous releases (cost). Female contamination must be kept extremely low (sexing technology).
• Long-term stability of virus blocking is monitored (it has been stable in Australia for more than 10 years so far).

Evidence of displacement — D2: measurable displacement (minority share)#

Assessment (hand-reviewed): City programmes: Wolbachia cut perifocal insecticide spraying by 83% in Yogyakarta (peer-reviewed); insecticide-treated properties fell 17-fold in Medellín in 2021 (with caveats).

Verified figures (the number is in the quoted sentence and the sentence is on the source page):

• displacement — In Yogyakarta, Indonesia, the deployment of Wolbachia-infected mosquitoes led to an 83% reduction in the frequency of perifocal insecticide fogging applications by public health teams. (Yogyakarta, Indonesia, 2016-2022; peer-reviewed: exa.ai)
• displacement — Deployments of wMel-infected Aedes aegypti mosquitoes in Yogyakarta City resulted in an 83% reduction in the application of perifocal insecticide spraying. (Yogyakarta City, Indonesia, 2023; peer-reviewed: pubmed.ncbi.nlm.nih.gov)
• displacement — In Medellin, Colombia, the number of properties treated with insecticides was 17 times lower in 2021 compared to 2020. (Medellin, Colombia, 2021; peer-reviewed: journals.plos.org)
• economics — The annual cost spent on insecticide fogging in Yogyakarta City was reduced by 39.6% following the deployment of Wolbachia-infected mosquitoes. (Yogyakarta, Indonesia, 2016-2019; peer-reviewed: exa.ai)

Suppliers — real products and services (from the vendor index)#

Honest finding: the vendor index has no Wolbachia mosquito programme; entries are sterile-insect capability in agriculture. This is recorded as a supplier gap — the companies below are the closest capabilities.

Companies below are active vendors in the vendor index whose own card (profile / official website) shows this product or service — matched 2026-09-28 by keyword and checked by hand against the card text. Being listed is not an endorsement; open each card for evidence, contacts and status.

Update 2026-10-02: the new USA & Canada dataset supplies this product — rows marked NA below. For Africa/ME, LatAm and Asia the regional gap noted above still stands.

Update 2026-10-05: the new Europe dataset adds the closest capabilities — rows marked Europe below; the gap noted above still stands.

Government funding signals#

Public grants for a specific technology are a leading indicator: governments fund what regulators want to replace and what is close to practical adoption. Searched on 2026-09-27 in: EU CORDIS (FP7, Horizon 2020, Horizon Europe), US federal awards (USAspending: USDA NIFA/ARS/APHIS/Forest Service, EPA, DOE, NOAA, USAID; plus NSF and NIH), UK UKRI Gateway to Research, Australian Research Council. Each grant below was reviewed by hand for relevance. China, Brazil and India are covered in the subsection below (publication-acknowledged grants). Not covered: Russia (RSF, FASIE — not reachable from the research environment) and national agencies outside these databases. Amounts are the funder’s contribution as recorded (US NIH/UKRI: per award or fiscal year).

Signal: Strong. 3 relevant grant(s) · about €3.3M in total · jurisdictions: Australia, UK.

China, Brazil, India — national research grants acknowledged in publications#

Chinese, Brazilian and Indian funders have no open grant databases reachable here, so this measures scientific papers published since 2015 that acknowledge national government grants, taken from the grant numbers publishers deposit with Crossref. Only papers whose title contains this article’s key terms are counted (a conservative lower bound; “100+” = search window full). It shows research-funding intensity, not budgets. Funders: China — NSFC, National Key R&D Program, China Agriculture Research System; Brazil — CNPq, CAPES, FAPESP, Embrapa, FAPEMIG; India — DBT, DST, ICAR, SERB, CSIR, BIRAC. Rating per country: Strong ≥50 papers · Moderate 10–49 · Weak 1–9.

Scientific evidence#

• Utarini A, Indriani C, Ahmad RA, et al. (2021). Efficacy of Wolbachia-infected mosquito deployments for the control of dengue. New England Journal of Medicine 384: 2177–2186.
• Hoffmann AA, Montgomery BL, Popovici J, et al. (2011). Successful establishment of Wolbachia in Aedes populations to suppress dengue transmission. Nature 476: 454–457.
• Zheng X, Zhang D, Li Y, et al. (2019). Incompatible and sterile insect techniques combined eliminate mosquitoes. Nature 572: 56–61.
• Moyes CL, Vontas J, Martins AJ, et al. (2017). Contemporary status of insecticide resistance in the major Aedes vectors of arboviruses infecting humans. PLoS Neglected Tropical Diseases 11: e0005625.

Bioeconomy value#

A natural bacterium and insect biotechnology replace recurring urban insecticide campaigns. This is a public-health bioeconomy with local mass-rearing jobs.